Expression of KL-6/MUC1 in pancreatic ductal carcinoma and its potential relationship with β-catenin in tumor progression

Life Sciences - Tập 88 - Trang 1063-1069 - 2011
Huanli Xu1,2, Yoshinori Inagaki1, Yasuji Seyama1, Kiyoshi Hasegawa1, Yasuhiko Sugawara1, Guanhua Du2, Fengshan Wang3, Wei Tang1, Norihiro Kokudo1
1Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, the University of Tokyo, Tokyo 113–8655, Japan
2Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, China
3Institute of Biochemical and Biotechnological Drugs, School of Pharmaceutical Sciences, Shandong University, Jinan 250012, Shandong, China

Tài liệu tham khảo

Behrens, 2005, The role of the Wnt signaling pathway in colorectal tumorigenesis, Biochem Soc Trans, 33, 672, 10.1042/BST0330672 George, 2004, MMPs, cadherins, and cell proliferation, Trends Cardiovasc Med, 14, 100, 10.1016/j.tcm.2003.12.008 Guo, 2006, Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues, World J Gastroenterol, 12, 54, 10.3748/wjg.v12.i1.54 Heiser, 2008, Stabilization of beta-catenin induces pancreas tumor formation, Gastroenterology, 135, 1288, 10.1053/j.gastro.2008.06.089 Hollingsworth, 2004, Mucins in cancer: protection and control of the cell surface, Nat Rev Cancer, 4, 45, 10.1038/nrc1251 Huang, 2003, MUC1 cytoplasmic domain coactivates Wnt target gene transcription and confers transformation, Cancer Biol Ther, 2, 702, 10.4161/cbt.2.6.610 Huang, 2005, MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin, Cancer Res, 65, 10413, 10.1158/0008-5472.CAN-05-2474 Inagaki, 2009, Clinicopathology of sialomucin: MUC1, particularly KL-6 mucin, in gastrointestinal, hepatic and pancreatic cancers, Biosci Trends, 3, 220 Japan Pancreas Society, 2002 Kohlgraf, 2003, Contribution of the MUC1 tandem repeat and cytoplasmic tail to invasive and metastatic properties of a pancreatic cancer cell line, Cancer Res, 63, 5011 Kohno, 1988, Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma, Jpn J Clin Oncol, 18, 203 Kohno, 1994, Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9, Int J Cancer Suppl, 8, 81, 10.1002/ijc.2910570717 Li, 1998, Interaction of glycogen synthase kinase 3β with the DF3/MUC1 carcinoma-associated antigen and β-catenin, Mol Cell Biol, 18, 7216, 10.1128/MCB.18.12.7216 Li, 2001, The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin, J Biol Chem, 276, 35239, 10.1074/jbc.C100359200 Luttges, 2002, The mucin profile of noninvasive and invasive mucinous cystic neoplasms of the pancreas, Am J Surg Pathol, 26, 466, 10.1097/00000478-200204000-00008 Nelson, 2003, VE-cadherin simultaneously stimulates and inhibits cell proliferation by altering cytoskeletal structure and tension, J Cell Sci, 116, 3571, 10.1242/jcs.00680 Raina, 2004, The MUC1 oncopro-tein activates the anti-apoptotic phosphoinositide 3-kinase/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts, J Biol Chem, 279, 20607, 10.1074/jbc.M310538200 Schneider, 2005, Pancreatic cancer: basic and clinical aspects, Gastroenterology, 128, 1606, 10.1053/j.gastro.2005.04.001 Schroeder, 2003, MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion, Oncogene, 22, 1324, 10.1038/sj.onc.1206291 Sobin, 1997 Stockinger, 2001, E-cadherin regulates cell growth by modulating proliferation-dependent β-catenin transcriptional activity, J Cell Biol, 154, 1185, 10.1083/jcb.200104036 Tang, 2005, KL-6 mucin expression in carcinoma of the ampulla of Vater: association with cancer progression, World J Gastroenterol, 11, 5450, 10.3748/wjg.v11.i35.5450 Wen, 2003, Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin, J Biol Chem, 278, 38029, 10.1074/jbc.M304333200 Wesseling, 1995, Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components, J Cell Biol, 129, 255, 10.1083/jcb.129.1.255 Xu, 2008, Elevation of serum KL-6 mucin levels in patients with cholangiocarcinoma, Hepatogastroenterology, 55, 2000 Xu, 2008, Effect of benzyl-N-acetyl-α-galactosaminide on KL-6 mucin expression and invasive properties of a human pancreatic carcinoma cell line, Drug Discov Ther, 2, 282 Xu, 2009, Expression of KL-6 mucin, a human MUC1 mucin, in intrahepatic cholangiocarcinoma and its potential involvement in tumor cell adhesion and invasion, Life Sci, 85, 395, 10.1016/j.lfs.2009.07.004 Yin, 2003, Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress, J Biol Chem, 278, 35458, 10.1074/jbc.M301987200 Zhang, 2008, Positive KL-6 mucin expression combined with decreased membranous beta-catenin expression indicates worse prognosis in colorectal carcinoma, Oncol Rep, 20, 1013